CN1475244A - Antivirus oral liquid - Google Patents

Antivirus oral liquid Download PDF

Info

Publication number
CN1475244A
CN1475244A CNA021364745A CN02136474A CN1475244A CN 1475244 A CN1475244 A CN 1475244A CN A021364745 A CNA021364745 A CN A021364745A CN 02136474 A CN02136474 A CN 02136474A CN 1475244 A CN1475244 A CN 1475244A
Authority
CN
China
Prior art keywords
gypsum fibrosum
mirabilitum crystallina
oral liquid
effect
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CNA021364745A
Other languages
Chinese (zh)
Other versions
CN1308021C (en
Inventor
吴圣楣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB021364745A priority Critical patent/CN1308021C/en
Publication of CN1475244A publication Critical patent/CN1475244A/en
Application granted granted Critical
Publication of CN1308021C publication Critical patent/CN1308021C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

An antiviral oral liquid for treating viral cold, pharyngitis, acute bronchitis, tonsillitis and parotitis is prepared from at least 4 Chinese-medicinal materials including scutellaria root, gypsum, gypsum rubrum, etc. Its advantages are high curative effect 95.6%, no by-effect, low cost, and no recurrence.

Description

Antivirus oral liquid
The present invention relates to a kind of pure Chinese medicine oral liquid---antivirus oral liquid that viral infection etc. causes heating for the treatment of.
The heating that viral infection causes is common clinically disease, but the treatment of the heating that viral infection is caused mainly is a symptomatic treatment owing to lack antiviral specific medicament, as having a rest, great quantity of water drinking, reduces temperature and mitigation symptoms.Antipyretic commonly used such as acetaminophen, hundred clothes are given repeated exhortations, paracetamol etc. owing to do not have antivirus action, after bringing down a fever easily repeatedly.Have the medicine of antivirus action such as interferon etc. and but do not have the antipyretic effect, can cause heating on the contrary, can not alleviate patient's symptom, and need drug administration by injection, use inconveniently, the price of medicine is also expensive, causes certain financial burden to patient.Other antiviral drugs commonly used mainly are nucleoside analogs, by disturbing the synthetic of DNA, suppress viral dna polymerase and bring into play antiviral effect, as vidarabine (Ara-a) and Ara-AMP, but its late result is not better than the placebo group, and bigger toxicity, side effect is arranged.The ucleosides antiviral drugs lamivudine of a new generation also has side reactions such as headache, discomfort, tired, stomachache and diarrhoea, and costs an arm and a leg.Whether is there there a kind of cheap and good-quality medicine, existing antiviral effect, the effect that having again brings down a fever alleviates patient symptom?
The purpose of this invention is to provide that a kind of therapeutic effect is remarkable, side effect is little, cost is lower, have heat-clearing and toxic substances removing, the pure Chinese medicinal preparation of antiviral effect.Be mainly used in viral infection such as viral influenza, pharyngitis, acute bronchitis, tonsillitis, parotitis and cause the treatment of heating.
Purpose of the present invention can reach by the following method: made by Rhizoma Paridis, Radix Scutellariae, Gypsum Fibrosum, Mirabilitum crystallina four flavor Chinese medicines, the ratio between the four flavor Chinese medicines (parts by weight) is a Rhizoma Paridis: Radix Scutellariae: Gypsum Fibrosum: Mirabilitum crystallina=3~20: 5~15: 5~70: 3~40.Can add on the basis of this four Chinese medicine that also other Chinese medicines such as Radix Isatidis, Radix Glycyrrhizae etc. increase the curative effect of medicine.Its processing technology is that Gypsum Fibrosum and Mirabilitum crystallina added decocting earlier 20~60 minutes with medical herbs immersion (submergence) 1~2 hour, and then with medical herbs and Gypsum Fibrosum is put in immersion and the Mirabilitum crystallina decocting liquid was fried in shallow oil 20~60 minutes together again, filtered juice is a medicinal liquid.
The present invention is on the basis of clinical practice for many years, goes through years of researches, adjusts prescription and dosage and makes.Infect the medicine cause and compared tangible advantage with the existing poison that is used for the treatment of, after the Drug therapy with this prescription, patient's heat is stepped back and is difficult for repeatedly, and the effect of bringing down a fever is remarkable.Rhizoma Paridis in the present invention prescription has antimicrobial, relievings asthma, antitussive action; Radix Scutellariae has antimicrobial, antiinflammatory antiallergic action, antipyretic effect; The main component of Gypsum Fibrosum is a hydrous calcium sulfate, and report has antipyretic effect; Mirabilitum crystallina has resolving heat and reducing pathogenic fire, sharp key, repercussive effect.Four Chinese medicine is combined, and has complementary and collaborative effect through special its curative effect of the oral liquid of being processed into, and has heat-clearing and toxic substances removing, antiviral effect.Be used for the treatment that viral infection such as viral influenza, pharyngitis, acute bronchitis, tonsillitis, parotitis cause heating effectively.Clinical studies show is divided into two groups at random with the fever patient (38 ℃~40 ℃ of body temperature) of 2658 routine viral infection, and wherein among the 1658 routine patients with the antivirus oral liquid treatment, the 2nd day body temperature of 1585 examples returns to normally, and not repeatedly; And in the fever patient that the 1000 routine viral infection for the treatment of with acetaminophen cause, have only 460 examples the 2nd
It body temperature returns to normally, not repeatedly.Evident difference is relatively arranged between two groups
(P<0.01)。Show that the heating that antivirus oral liquid causes viral infection has tangible curative effect, do blood, urine, stool routine and hepatic and renal function inspection before and after the treatment, no abnormality seen changes, and have no side effect, and processing technology is simple, and cost is lower.
The present invention is further described in conjunction with the embodiments: antivirus oral liquid adds that by Rhizoma Paridis, Radix Scutellariae, Gypsum Fibrosum, Mirabilitum crystallina four flavor Chinese medicines Radix Isatidis makes, and the ratio of Chinese medicine of the five flavours (parts by weight) is a Rhizoma Paridis: Radix Scutellariae: Radix Isatidis: give birth to cream: Mirabilitum crystallina=15: 10: 15: 60: 30.With three flavor medical herbs immersions (submergence) 1 hour, Gypsum Fibrosum and Mirabilitum crystallina were decocted first 20 minutes, then the immersion of medical herbs and medical herbs were put into Gypsum Fibrosum and Mirabilitum crystallina and fried in shallow oil together 20 minutes again, and filtrate both had been medicine.Usage and dosage: 3 times on the oral one, shared two days, each consumption: 6 months~3 years old 15 milliliters; 3~10 years old 50 milliliters; More than 10 years old 100 milliliters.

Claims (3)

1. pure Chinese medicine oral liquid for the treatment of viral infection, its feature is mainly made by Rhizoma Paridis, Radix Scutellariae, Gypsum Fibrosum, Mirabilitum crystallina four flavor Chinese medicines, and the ratio between the four flavor Chinese medicines (parts by weight) is a Rhizoma Paridis: Radix Scutellariae: Gypsum Fibrosum: Mirabilitum crystallina=3~20: 5~15: 5~70: 3~40.
2. add on the basis of the described four Chinese medicine of claim 1 that other Chinese medicines such as Radix Isatidis, Radix Glycyrrhizae etc. increase the curative effect of medicine.
3. with medical herbs immersion (submergence) 1~2 hour, Gypsum Fibrosum and Mirabilitum crystallina were decocted first 20~60 minutes, and then with medical herbs and Gypsum Fibrosum is put in immersion and the Mirabilitum crystallina decocting liquid was fried in shallow oil 20~60 minutes together again, filtered juice is a medicinal liquid.
CNB021364745A 2002-08-13 2002-08-13 Antivirus oral liquid Expired - Fee Related CN1308021C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB021364745A CN1308021C (en) 2002-08-13 2002-08-13 Antivirus oral liquid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB021364745A CN1308021C (en) 2002-08-13 2002-08-13 Antivirus oral liquid

Publications (2)

Publication Number Publication Date
CN1475244A true CN1475244A (en) 2004-02-18
CN1308021C CN1308021C (en) 2007-04-04

Family

ID=34146490

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB021364745A Expired - Fee Related CN1308021C (en) 2002-08-13 2002-08-13 Antivirus oral liquid

Country Status (1)

Country Link
CN (1) CN1308021C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102940856A (en) * 2012-12-12 2013-02-27 杭州老桐君制药有限公司 Method for preparing anti-viral oral liquid and product thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1052902C (en) * 1996-01-15 2000-05-31 贺力坤 Method for preparation of drug for curing acute epidemic febrile disease
CN1244421A (en) * 1999-05-27 2000-02-16 刘成业 Preparation of antiviral Guzaoke

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102940856A (en) * 2012-12-12 2013-02-27 杭州老桐君制药有限公司 Method for preparing anti-viral oral liquid and product thereof

Also Published As

Publication number Publication date
CN1308021C (en) 2007-04-04

Similar Documents

Publication Publication Date Title
CN101322776A (en) Chinese medicinal composition for treating exogenous fever and preparation thereof
CN102836333A (en) Medicine composition for treating fever of unknown origin as well as preparation method and application thereof
CN104857436B (en) Traditional Chinese medicine compound composition with resisting liver cancer activity and its preparation method and application
CN103381266A (en) Traditional Chinese medicine for treating nervous vomiting
CN102552512A (en) Traditional Chinese medicine used for treating hepatitis B
CN1308021C (en) Antivirus oral liquid
CN104623379B (en) A kind of pharmaceutical composition for the treatment of Hand-Food-Mouth Disease
CN103272111A (en) Traditional Chinese medicine liquor for treating toothache
CN102793876A (en) Pharmaceutical composition for treating fever caused by unknown reason as well as preparation method and application of pharmaceutical composition
CN102631607B (en) Medicament for treating cardiovascular diseases and preparation method thereof
CN1294961C (en) Oral liquid for curing myocardial ischemia and process for preparing the same
CN1387891A (en) Chinese medicine prepn for treating deficiency of spleen and stomach Yang type atrophic gastritis
CN104225387A (en) Traditional Chinese medicine composition for treating damp-heat blocked type diabetes feet
CN103006950A (en) Traditional Chinese medicine for treating pharyngolaryngitis and preparation process thereof
CN1087623C (en) Antipyretic granular formulation containing ramulus cinnamomi, ephedra and bupleurum root
CN103479986B (en) The anti-medicine treated constipation
CN103479948B (en) The anti-medicine treated constipation
CN1248465A (en) Method for producing Anruneixiao medicinal liquid
CN102631618A (en) Traditional Chinese medicine for treating diabetes
CN100490873C (en) Medicinal composition for treating high fever and preparation method thereof
CN107551022A (en) Treatment table defends the compound preparation and preparation method of not solid caused nonallergic purpura
CN100444877C (en) A Chinese medicine for treating cholecystitis
CN1076622C (en) Chinese medicine for curing nephritis
CN101336990A (en) Medicine for treating cholecystitis
CN105521386A (en) Traditional Chinese medicinal composition for treating cough with syndrome of liver fire invading lung in children

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee